Latest posts by Lawrence F Muscarella PhD (see all)
- Questions the FDA May Soon Address in Response to Recent “Superbug” Outbreaks Linked to GI Endoscopes - January 29, 2015
- FDA Soliciting Public Comment on the Safe Use of Disposable Irrigation Tubing - January 23, 2015
- SEATTLE TIMES: “Undisclosed superbug sickened dozens at Virginia Mason” - January 22, 2015
Initial comments: The following blog is an abstract of my peer-reviewed article entitled “Assessment of the Reported Effectiveness of Five Different Quality-Improvement Initiatives for the Prevention of Central Line-Associated Bloodstream Infections in Intensive Care Units” (Muscarella LF. The Open Epidemiology Journal, 2012, 5, 5-12).
This peer-reviewed article about CLABSIs can be read in its entirety by clicking here.
Abstract: Five studies that evaluated five different quality-improvement initiatives for the prevention of central line-associated bloodstream infections (CLABSIs) in adult, pediatric and/or neonatal intensive care units (ICUs) and that were published within the past two years in an infection-control and epidemiology journal were reviewed, assessed and compared. Each is a prospective cohort study that similarly concludes that the evaluated initiative was responsible for a significant and calculated reduction in the CLABSI rate, ranging from 30.3% to 85%. The soundness of these conclusions and calculations, however, like the legitimacy of several other common uses of CLABSI data, requires, in addition to satisfying a number of other criteria, that each study’s CLABSI rates be accurate and complete. The primary goal of this analysis, therefore, was to confirm the hypothesis that each of these five studies had validated its CLABSI rates. The analysis found, however, that these five studies did not validate the accuracy and completeness of their CLABSI rates, which raises reasonable questions about each study’s assessment of and conclusions about the initiative’s effectiveness for the prevention of CLABSIs. In addition to their aims, calculations, and conclusions, these five studies share in common a number of features, as well as circumscribing qualities, which are discussed. The distinction between a qualitative assessment and a quantitative determination of an initiative’s performance is also discussed. Both the circumspective use of CLABSI data that have not been validated and the cautious interpretation of conclusions about central-line care that are based on these CLABSI data are recommended.
Blog by: Lawrence F Muscarella PhD posted on 12-21-12
- Advertise your infection control product here. Click here.
- Are you a medical facility? Click here.
- Are you a medical device manufacturer? Click here.